FDA Inspection 734735 — Bloodworks Northwest

Bloodworks Northwest — FEI 3071915

The FDA completed an inspection of Bloodworks Northwest on July 18, 2011 in Eugene, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 18, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Eugene, OR (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
8821 CFR 606.100(b)(9)Written methods for investigating adverse reactions